You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

CLINICAL TRIALS PROFILE FOR OBILTOXAXIMAB


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for obiltoxaximab

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01952444 ↗ Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers Completed Elusys Therapeutics Phase 1 2013-10-29 Evaluate the safety, tolerability and pharmacokinetics (PK) of intravenous (IV) ETI-204 alone and in the presence of IV and oral ciprofloxacin
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for obiltoxaximab

Condition Name

Condition Name for obiltoxaximab
Intervention Trials
Inhalational Anthrax 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for obiltoxaximab
Intervention Trials
Anthrax 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for obiltoxaximab

Trials by Country

Trials by Country for obiltoxaximab
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for obiltoxaximab
Location Trials
Kansas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for obiltoxaximab

Clinical Trial Phase

Clinical Trial Phase for obiltoxaximab
Clinical Trial Phase Trials
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for obiltoxaximab
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for obiltoxaximab

Sponsor Name

Sponsor Name for obiltoxaximab
Sponsor Trials
Elusys Therapeutics 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for obiltoxaximab
Sponsor Trials
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.